Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | Director | August 18, 2026 | August 19, 2026 |
| SAFEGUARD SCIENTIFICS INCSFE · Entity 9612 | Director · President & CEO | June 15, 2018 | June 18, 2018 |
| VIRTUS INVESTMENT PARTNERS, INC.VRTS · Entity 4916 | Director | March 06, 2024 | March 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date August 18, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-08-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-18 · Exercise / conversion · Acquired 25,000 · Balance 25,000 Row 2 · 2026-08-18 · Sale · Disposed 25,000 · Balance 0 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.92 to $87.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. |
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $53.27 · Expires 2030-01-22 | Direct | 0 |
Reported balance
After 2026-08-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-18 · Exercise / conversion · Disposed 25,000 · Balance 0 F2: These options were granted on January 22, 2020 and are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.92 to $87.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
F2: These options were granted on January 22, 2020 and are fully vested.
SAFEGUARD SCIENTIFICS INC
Report date June 15, 2018 · Filed June 18, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 180,014 |
Reported balance
After 2018-06-15 transaction · row 1
1 source rowRow 1 · 2018-06-15 · Tax withholding · Disposed 1,104 · Balance 180,014 |
| Common StockSEC Table I · non-derivative | IndirectSTZ DB Plan | 11,490 |
Reported balance
Holding disclosure · report date 2018-06-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 11,490 |
VIRTUS INVESTMENT PARTNERS, INC.
Report date March 06, 2024 · Filed March 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,549 |
Reported balance
After 2024-03-06 transaction · row 1
1 source rowRow 1 · 2024-03-06 · Sale · Disposed 2,150 · Balance 3,549 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2026 Filed Aug 19, 2026 21:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001193125-26-357121 · ownership.xml · derivative · entry 3 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,000 shares Expires 2030-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on January 22, 2020 and are fully vested. Read SEC document |
| August 18, 2026 Filed Aug 19, 2026 21:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 25,000 | $87.04 | $2,175,965.00 |
DisclosureSEC source: 0001193125-26-357121 · ownership.xml · nonDerivative · entry 2 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.92 to $87.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 18, 2026 Filed Aug 19, 2026 21:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 25,000 | $53.27 | $1,331,750.00 |
DisclosureSEC source: 0001193125-26-357121 · ownership.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:51 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $94.15 | $0.00 |
DisclosureSEC source: 0001193125-26-021201 · ownership.xml · derivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2036-01-21 F1 · derivative.exercise_date: These options were granted on January 21, 2026, and will vest on January 1, 2027. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $44.14 | $0.00 |
DisclosureSEC source: 0001193125-25-280472 · ownership.xml · derivative · entry 3 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,000 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 1, 2019 and are fully vested. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 25,000 | $84.29 | $2,107,257.50 |
DisclosureSEC source: 0001193125-25-280472 · ownership.xml · nonDerivative · entry 2 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.11 to $84.65, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 25,000 | $44.14 | $1,103,500.00 |
DisclosureSEC source: 0001193125-25-280472 · ownership.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2025 Filed Mar 28, 2025 22:35 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $92.42 | $0.00 |
DisclosureSEC source: 0000950170-25-047017 · ownership.xml · derivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2035-01-23 F1 · derivative.exercise_date: These options were granted on January 23, 2025, and will vest on January 1, 2026. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:49 UTC | VIRTUS INVESTMENT PARTNERS, INC. VRTS · Entity 4916 | SaleCommon Stock | 2,150 | $248.40 | $534,054.63 |
DisclosureSEC source: 0000883237-24-000027 · wk-form4_1709848184.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,549 Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 22:08 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $53.75 | $0.00 |
DisclosureSEC source: 0000950170-24-008954 · ownership.xml · derivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2034-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2024, and will vest on January 1, 2025. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:28 UTC | VIRTUS INVESTMENT PARTNERS, INC. VRTS · Entity 4916 | GrantCommon Stock | 602 | $178.54 | $107,481.08 |
DisclosureSEC source: 0000883237-23-000066 · wf-form4_168452806923095.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,699 F1 · shares: Common Stock issued as a portion of the Reporting Person's compensation as a member of the Board of Directors in accordance with the Company's Amended and Restated Omnibus Incentive and Equity Plan and subject to share ownership guidelines. Read SEC document |
| January 26, 2023 Filed Feb 27, 2023 22:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $75.18 | $0.00 |
DisclosureSEC source: 0001209191-23-013253 · doc4.xml · derivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2033-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:37 UTC | VIRTUS INVESTMENT PARTNERS, INC. VRTS · Entity 4916 | GrantCommon Stock | 585 | $175.00 | $102,375.00 |
DisclosureSEC source: 0000883237-22-000198 · wf-form4_165307899959080.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,097 F1 · shares: Common Stock issued as a portion of the Reporting Person's compensation as a member of the Board of Directors in accordance with the Company's Amended and Restated Omnibus Incentive and Equity Plan and subject to share ownership guidelines. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $63.68 | $0.00 |
DisclosureSEC source: 0001209191-22-005621 · doc4.xml · derivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2032-01-27 F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 21:28 UTC | VIRTUS INVESTMENT PARTNERS, INC. VRTS · Entity 4916 | SaleCommon Stock | 1,808 | $280.55 | $507,240.37 |
DisclosureSEC source: 0000883237-21-000217 · wf-form4_162819878799867.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,512 Read SEC document |
| May 14, 2021 Filed May 17, 2021 21:28 UTC | VIRTUS INVESTMENT PARTNERS, INC. VRTS · Entity 4916 | GrantCommon Stock | 367 | $268.04 | $98,370.68 |
DisclosureSEC source: 0000883237-21-000150 · wf-form4_162128691307683.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,320 F1 · shares: Common Stock issued as a portion of the Reporting Person's compensation as a member of the Board of Directors in accordance with the Company's Amended and Restated Omnibus Incentive and Equity Plan and subject to share ownership guidelines. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 21:56 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $65.05 | $0.00 |
DisclosureSEC source: 0001209191-21-004043 · doc4.xml · derivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2031-01-14 F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:33 UTC | VIRTUS INVESTMENT PARTNERS, INC. VRTS · Entity 4916 | GrantCommon Stock | 1,138 | $89.16 | $101,464.08 |
DisclosureSEC source: 0000883237-20-000107 · wf-form4_158992398356175.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,953 F1 · shares: Common Stock issued as a portion of the Reporting Person's compensation as a member of the Board of Directors in accordance with the Company's Amended and Restated Omnibus Incentive and Equity Plan and subject to share ownership guidelines. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:49 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-20-004870 · doc4.xml · derivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2030-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:26 UTC | VIRTUS INVESTMENT PARTNERS, INC. VRTS · Entity 4916 | GrantCommon Stock | 902 | $117.78 | $106,237.56 |
DisclosureSEC source: 0000883237-19-000067 · wf-form4_155804200281321.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,815 F1 · shares: Common Stock issued as a portion of the Reporting Person's compensation as a member of the Board of Directors in accordance with the Company's Amended and Restated Omnibus Incentive and Equity Plan and subject to share ownership guidelines. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:21 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $44.14 | $0.00 |
DisclosureSEC source: 0001209191-19-027358 · doc4.xml · derivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2029-05-01 F1 · derivative.exercise_date: These options were granted on May 1, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on May 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 14:59 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 1,104 | $13.18 | $14,545.20 |
DisclosureSEC source: 0000086115-18-000061 · wf-form4_152933395901242.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,014 Read SEC document |
| May 15, 2018 Filed May 16, 2018 21:33 UTC | VIRTUS INVESTMENT PARTNERS, INC. VRTS · Entity 4916 | GrantCommon Stock | 856 | $124.00 | $106,144.00 |
DisclosureSEC source: 0000883237-18-000063 · wf-form4_152650638188366.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,913 F1 · shares: Common Stock issued as a portion of the Reporting Person's compensation as a member of the Board of Directors in accordance with the Company's Amended and Restated Omnibus Incentive and Equity Plan and subject to share ownership guidelines. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 17:33 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 1,104 | $12.68 | $13,993.20 |
DisclosureSEC source: 0000086115-18-000041 · wf-form4_152122161226088.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,118 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 13:57 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 2,526 | $12.33 | $31,132.95 |
DisclosureSEC source: 0000086115-18-000030 · wf-form4_152025821811789.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,222 Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 20:21 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 56,495 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-18-000008 · wf-form4_151492448135880.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,748 Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 14:41 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 633 | $11.40 | $7,216.20 |
DisclosureSEC source: 0000086115-17-000148 · wf-form4_151360805487126.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,253 Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 15:09 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 54 | $12.23 | $660.15 |
DisclosureSEC source: 0000086115-17-000141 · wf-form4_151084494333631.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,886 Read SEC document |
| October 15, 2017 Filed Oct 16, 2017 18:58 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 54 | $14.15 | $764.10 |
DisclosureSEC source: 0000086115-17-000123 · wf-form4_150818030803852.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,940 Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 17:22 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 686 | $12.95 | $8,883.70 |
DisclosureSEC source: 0000086115-17-000110 · wf-form4_150575535327522.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,994 Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 19:31 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 54 | $11.80 | $637.20 |
DisclosureSEC source: 0000086115-17-000105 · wf-form4_150291189197281.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,680 Read SEC document |
| July 15, 2017 Filed Jul 18, 2017 15:42 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 54 | $12.63 | $681.75 |
DisclosureSEC source: 0000086115-17-000087 · wf-form4_150039256296568.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,734 Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 13:42 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 687 | $11.50 | $7,900.50 |
DisclosureSEC source: 0000086115-17-000077 · wf-form4_149762051890607.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,788 Read SEC document |
| May 19, 2017 Filed May 23, 2017 00:34 UTC | VIRTUS INVESTMENT PARTNERS, INC. VRTS · Entity 4916 | GrantCommon Stock | 976 | $103.70 | $101,211.20 |
DisclosureSEC source: 0000883237-17-000067 · wf-form4_149549965580545.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,057 F1 · shares: Common Stock issued as a portion of the Reporting Person's compensation as a member of the Board of Directors in accordance with the Company's Amended and Restated Omnibus Incentive and Equity Plan and subject to share ownership guidelines. Read SEC document |
| May 15, 2017 Filed May 16, 2017 18:10 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 54 | $11.78 | $635.85 |
DisclosureSEC source: 0000086115-17-000059 · wf-form4_149495823668146.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,475 Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 13:24 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Exercise / conversionStock Option (right to buy) · Derivative | 3,625 | $9.83 Strike: $9.83 | $35,615.63 |
DisclosureSEC source: 0000086115-17-000049 · wf-form4_149269465092097.xml · derivative · entry 4 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,625 shares Expires 2017-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option vested 25% on October 30, 2010 and the remaining 75% vested in 36 equal monthly installments on the same date of each calendar month thereafter. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 13:24 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 2,849 | $12.50 | $35,612.50 |
DisclosureSEC source: 0000086115-17-000049 · wf-form4_149269465092097.xml · nonDerivative · entry 2 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,529 Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 13:24 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Exercise / conversionCommon Stock | 3,625 | $9.83 | $35,615.63 |
DisclosureSEC source: 0000086115-17-000049 · wf-form4_149269465092097.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2017 Filed Apr 17, 2017 16:59 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 54 | $12.40 | $669.60 |
DisclosureSEC source: 0000086115-17-000047 · wf-form4_149244833190090.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,753 Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 14:18 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 686 | $12.33 | $8,454.95 |
DisclosureSEC source: 0000086115-17-000034 · wf-form4_148967387517428.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,807 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 15:25 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 1,588 | $12.64 | $20,072.32 |
DisclosureSEC source: 0000086115-17-000026 · wf-form4_148846830910863.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,493 Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 16:03 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 63 | $12.85 | $809.55 |
DisclosureSEC source: 0000086115-17-000019 · wf-form4_148726102062253.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,081 Read SEC document |
| January 15, 2017 Filed Jan 17, 2017 13:50 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 63 | $13.34 | $840.26 |
DisclosureSEC source: 0000086115-17-000009 · wf-form4_148466104583337.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,144 Read SEC document |
| December 30, 2016 Filed Dec 30, 2016 17:55 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 29,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-16-000342 · wf-form4_148312052394671.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,207 Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 14:44 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 425 | $12.35 | $5,248.75 |
DisclosureSEC source: 0000086115-16-000335 · wf-form4_148189947427596.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,293 Read SEC document |
| December 05, 2016 Filed Dec 6, 2016 18:02 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 94 | $11.77 | $1,106.15 |
DisclosureSEC source: 0000086115-16-000328 · wf-form4_148104731776021.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,718 Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 16:29 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 79 | $11.93 | $942.08 |
DisclosureSEC source: 0000086115-16-000322 · wf-form4_147931377694171.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,812 Read SEC document |
| November 05, 2016 Filed Nov 7, 2016 15:21 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 95 | $10.95 | $1,040.25 |
DisclosureSEC source: 0000086115-16-000317 · wf-form4_147853207730033.xml · nonDerivative · entry 1 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,891 Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 15:42 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | PurchaseCommon Stock | 1,100 | $11.85 | $13,035.00 |
DisclosureSEC source: 0000086115-16-000312 · wf-form4_147801493587495.xml · nonDerivative · entry 3 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · STZ DB Plan Disclosed balance after: 11,490 Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 15:42 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | PurchaseCommon Stock | 500 | $11.84 | $5,921.50 |
DisclosureSEC source: 0000086115-16-000312 · wf-form4_147801493587495.xml · nonDerivative · entry 2 ZARRILLI STEPHEN T · CIK 0001203410 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · STZ DB Plan Disclosed balance after: 10,390 F1 · price: The purchase price reported is the average purchase price paid for the shares. The shares were purchased at prices ranging from $11.825 to $11.85. Reporting person will provide, upon the request of the SEC staff, the issuer or its shareowners, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.